SISRAM MED (01696) announced the launch of its PixelPeel™ Safe Laser Resurfacing Treatment solution, designed to meet the growing demand for safe, effective skin renewal treatments with minimal downtime. The solution is fully integrated into the new generation Alma Pixel™ and Alma Hybrid device systems.
The treatment has been initially launched in North America with plans for gradual global market rollout. PixelPeel™ utilizes clinically recognized gold standard laser energy combined with pixel-level precision, incorporating Alma's proprietary MotionSync™ technology to ensure safe, uniform, and controlled treatment delivery that effectively improves skin texture, tone, and radiance.
The solution is suitable for both first-time treatment seekers and individuals pursuing long-term skin maintenance programs. PixelPeel™ delivers efficient clinical results while offering short recovery periods and compatibility with all skin types.
The company believes PixelPeel™ will provide medical institutions and patients with advanced treatment protocols that meet current market demands, delivering a more convenient and efficient skincare experience. The comprehensive application of PixelPeel™ across Alma Pixel™ and Alma Hybrid devices creates innovative treatment solutions, further expanding the market coverage of existing device systems while enhancing device procurement and utilization rates.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.